
Do Medications Really Expire?
For most people, the beginning of March means spring cleaning — but have you ever thought of spring cleaning your medicine cabinet? It is important

For most people, the beginning of March means spring cleaning — but have you ever thought of spring cleaning your medicine cabinet? It is important

Patient assistance dollars from pharmaceutical companies have been a growing area in recent years. Assistance dollars have risen exponentially as pharmaceutical companies work to get

There seems to be enthusiasm as we all turn our backs on 2021. Enthusiasm for 2022 is coming with a much more cautious tone. In

In 2020, the world experienced an incredibly fast vaccine approval, with the Pfizer COVID-19 vaccine receiving emergency use authorization from the U.S. Food and Drug

Diabetes Management Diabetes is a complex and progressive medical condition associated with abnormally elevated blood sugar levels. If left untreated or uncontrolled, diabetes may cause

Lowering Costs and Improving Participant Experience In the constantly evolving pharmacy benefit management (PBM) industry, pharmacy expenses and participants’ expectations continue to rise. To keep

In case you missed it, National CooperativeRx produced a webinar educating the audience on biologic drugs and regulatory implications, the current market status of biosimilars and

The Cooperative’s new Advanced Criteria Updates Program has officially launched! National CooperativeRx constantly monitors the pharmaceutical marketplace for new therapies in the pipeline. We have

Ensure Proper Rebate Benefits for Your Company Prescription drug costs are at an all-time high with no end in sight for both self-funded plan sponsors

The number of unused medications in American households has significantly increased in recent years, resulting in excess waste. According to a recent study, approximately two

U.S. Supreme Court Ruling on ERISA The Employee Retirement Income Security Act of 1974 (ERISA) sets minimum standards for most private health plans and preempts

The week is finally here! Our specialty high-dollar claim review program launches this Thursday, October 1. This program will focus on reviewing indication-specific dosing of